MUCCI, Armida
 Distribuzione geografica
Continente #
EU - Europa 22.561
NA - Nord America 13.679
AS - Asia 8.842
SA - Sud America 1.232
Continente sconosciuto - Info sul continente non disponibili 735
AF - Africa 98
OC - Oceania 30
AN - Antartide 1
Totale 47.178
Nazione #
US - Stati Uniti d'America 13.404
RU - Federazione Russa 12.349
IT - Italia 3.764
SG - Singapore 3.291
IE - Irlanda 2.134
CN - Cina 1.582
HK - Hong Kong 1.450
UA - Ucraina 1.074
BR - Brasile 1.040
GB - Regno Unito 938
VN - Vietnam 880
DE - Germania 638
FR - Francia 464
JP - Giappone 413
KR - Corea 360
FI - Finlandia 302
SE - Svezia 286
TR - Turchia 282
IN - India 257
GR - Grecia 235
CA - Canada 128
NL - Olanda 115
BD - Bangladesh 75
AR - Argentina 72
ES - Italia 66
MX - Messico 56
IQ - Iraq 40
AT - Austria 34
PL - Polonia 31
BE - Belgio 30
ID - Indonesia 29
AU - Australia 27
CO - Colombia 27
EC - Ecuador 27
ZA - Sudafrica 24
PK - Pakistan 23
VE - Venezuela 20
MA - Marocco 19
SA - Arabia Saudita 19
CR - Costa Rica 18
CH - Svizzera 17
TW - Taiwan 17
UZ - Uzbekistan 17
CZ - Repubblica Ceca 14
EG - Egitto 13
RO - Romania 13
EU - Europa 12
JM - Giamaica 12
CL - Cile 11
NP - Nepal 11
NO - Norvegia 10
PE - Perù 10
PY - Paraguay 10
IL - Israele 9
MY - Malesia 9
NI - Nicaragua 9
UY - Uruguay 9
AE - Emirati Arabi Uniti 8
JO - Giordania 8
KE - Kenya 8
TH - Thailandia 8
TT - Trinidad e Tobago 8
AL - Albania 7
GT - Guatemala 7
HN - Honduras 7
PT - Portogallo 7
AZ - Azerbaigian 6
DK - Danimarca 6
ET - Etiopia 6
IR - Iran 6
PH - Filippine 6
SN - Senegal 6
TN - Tunisia 6
BO - Bolivia 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
SC - Seychelles 5
BA - Bosnia-Erzegovina 4
CY - Cipro 4
EE - Estonia 4
KZ - Kazakistan 4
PA - Panama 4
PR - Porto Rico 4
SV - El Salvador 4
AM - Armenia 3
BH - Bahrain 3
BS - Bahamas 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
LT - Lituania 3
LU - Lussemburgo 3
NZ - Nuova Zelanda 3
OM - Oman 3
BB - Barbados 2
BW - Botswana 2
DM - Dominica 2
GA - Gabon 2
HT - Haiti 2
KW - Kuwait 2
MN - Mongolia 2
Totale 46.425
Città #
Moscow 4.361
Dublin 2.124
Jacksonville 1.671
San Jose 1.528
Hong Kong 1.426
Santa Clara 1.396
Singapore 1.313
Ashburn 1.178
Chandler 1.022
Council Bluffs 853
Milan 370
Princeton 338
Ho Chi Minh City 324
Seoul 324
Roxbury 277
Beijing 263
Naples 221
Dallas 212
Hanoi 202
Rome 197
Medford 191
Bremen 172
Cambridge 167
Hefei 163
Caserta 156
Ann Arbor 151
Wilmington 150
New York 147
Woodbridge 138
Los Angeles 130
Boardman 127
Bengaluru 118
The Dalles 115
Aversa 106
Istanbul 103
San Mateo 79
São Paulo 79
Des Moines 74
Miano 66
Nanjing 61
Orem 58
Da Nang 57
Bari 54
Munich 53
Mountain View 46
Chicago 44
Atlanta 41
Pune 41
Houston 40
Norwalk 39
Redwood City 39
Turin 39
Frankfurt am Main 38
Memphis 37
Toronto 36
Düsseldorf 35
Rio de Janeiro 35
Jinan 34
Haiphong 32
Guangzhou 31
Palermo 30
Napoli 28
Bologna 27
Tianjin 27
Tokyo 27
Nanchang 26
Belo Horizonte 25
Catania 24
Helsinki 24
Montreal 24
San Francisco 24
Brasília 23
Brussels 23
Nuremberg 23
Venice 23
Afragola 22
Phoenix 22
Amsterdam 21
Auburn Hills 21
Denver 20
Hải Dương 19
Torino 19
Warsaw 19
Brooklyn 18
Perugia 18
Salerno 18
Turku 18
Vienna 18
Boston 17
Chennai 17
London 17
Miami 17
Shanghai 17
Bến Tre 16
Mexico City 16
San José 16
Brescia 15
Florence 15
Padova 15
Tashkent 15
Totale 23.746
Nome #
La riabilitazione cognitiva e psicosociale nei pazienti affetti da schizofrenia 1.214
Italian version of the "Specific Level of Functioning" 919
Cognitive Impairment after Post-Acute COVID-19 Infection: A Systematic Review of the Literature 297
Aspetti neuropsicofisiologici dei disturbi del comportamento alimentare: implicazioni per il trattamento 258
Big databases and biobanks for studying the links between CKD, cognitive impairment, and dementia 230
Training individualizzato delle abilità neuro cognitive e sociali (SSANIT) in pazienti psicotici cronici 221
Adult separation anxiety disorder: clinical characteristics and attachment styles 207
Cognitive impairment in CKD patients: a guidance document by the CONNECT network 202
EPA Guidance on treatment of cognitive impairment in schizophrenia 199
Cognitive deficits in psychotic disorders and their impact on social functioning 188
'Simple schizophrenia': a controlled MRI and clinical/neuropsychological study 186
A feasibility, acceptability and validation study of the Italian Version of a new cognitive remediation program for psychotic patients - CIRCuiTS 186
Survival from coma induced by an intentional 36-g overdose of extended-release quetiapine 185
Autism rating scale (ARS) - Italian version 181
Aetiopathological mechanisms of negative symptoms in schizophrenia 180
Abnormal Bodily Phenomena questionnaire - Italian version 180
EPA guidance on assessment of negative symptoms in schizophrenia 180
Premorbid academic and social functioning in patients with schizophrenia and its associations with negative symptoms and cognition 179
Translational research on cognitive impairment in chronic kidney disease 176
A multimodal DTI-fMRI investigation on illusions 170
Psychosis as a disorder of consciousness: Electrophysiological evidence 167
A large European, multicenter, multinational validation study of the Brief Negative Symptom Scale 167
Effectiveness of a social cognition remediation intervention for patients with schizophrenia: a randomized-controlled study 166
Characterization of premorbid functioning during childhood in patients with deficit vs. non-deficit schizophrenia and in their healthy siblings 165
Towards Precision Medicine in Psychosis: Benefits and Challenges of Multimodal Multicenter Studies-PSYSCAN: Translating Neuroimaging Findings From Research into Clinical Practice 165
Correlati neuropsicologici della remissione clinica nella schizofrenia 164
A psychophysiological investigation of emotional processing in subjects with panic disorder 163
Aspetti neuropsicologici dei disturbi del comportamento alimentare: implicazioni per il trattamento 162
Social skills and neurocognitive individualized training in schizophrenia: comparison with structured leisure activities 161
Chemotherapy-related cognitive impairment and kidney dysfunction 160
Interview Versus Performance Assessment of Cognition as Predictors of Real-World Outcomes in a Large-Scale Cross-Sectional Study in Schizophrenia 160
Advances in the understanding of the pathophysiology of schizophrenia and bipolar disorder through induced pluripotent stem cell models 160
COMT Val158Met and BDNF C270T polymorphisms in schizophrenia: a case-control study 160
Abnormalities of early visual ERP components elicited by both illusory and control stimuli in chronic schizophrenia 160
Abnormal bodily experiences detected by Abnormal Bodily Phenomena questionnaire are more frequent and severe in schizophrenia than in bipolar disorder with psychotic features 160
Acute Effects of Music Therapy in Subjects With Psychosis During Inpatient Treatment 159
Assessment of the role of cognitive control on monetary reward and loss anticipation: An electrophysiological study in subjects with schizophrenia 159
Assessment of de novo copy-number variations in Italian patients with schizophrenia: Detection of putative mutations involving regulatory enhancer elements 159
Anomalie dei potenziali evento-correlati durante l’ascolto dicotico nella schizofrenia 157
An EEG-based neuroimaging study of emotional processing in subjects with panic disorder 156
ANHEDONIA AND REAL-LIFE MOTIVATION IN PATIENTS WITH SCHIZOPHRENIA 155
Tecniche di neuroimaging ad alta risoluzione temporale nello studio della schizofrenia 154
Cognitive deficits and community functioning in chronic schizophrenia 154
Schizofrenia e disfunzioni della lateralizzazione emisferica: Risultati di uno studio sui potenziali evento-correlati registrati durante l'ascolto di toni monoaurali e dicotici 154
The implementation of cognitive remediation interventions in Campania 154
Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study 154
The Specific Level of Functioning Scale: Construct validity, internal consistency and factor structure in a large Italian sample of people with schizophrenia living in the community 153
The cortical generators of P3a and P3b: a LORETA study 153
Psychosocial functioning in remitted and non-remitted schizophrenic patients 153
Correlations between Negative Symptoms and Cognitive Deficits in Individuals at First Psychotic Episode or at High Risk of Psychosis: A Systematic Review 152
Neurocognitive functioning in subjects with eating disorders: the influence of neuroactive steroids 152
Attention/executive control systems hyperactivity in OCD 152
Avolition-Apathy and White Matter Connectivity in Schizophrenia: Reduced Fractional Anisotropy Between Amygdala and Insular Cortex 152
Avolition and microstructural brain abnormalities in Schizophrenia: Reduced fractional anisotropy in pathways connecting amygdala and insular cortex 152
The Brief Negative Symptom Scale (BNSS): Independent validation in a large sample of Italian patients with schizophrenia 151
Abnormalities of hemispheric lateralization in schizophrenic patients: a study using event-related potentials 150
Attention and context-updating processes in deficit and nondeficit schizophrenia: an ERP study 150
Lateralization patterns of verbal stimuli processing assessed by reaction time and event-related potentials in schizophrenic patients 149
Academic and social functioning in early life epochs in schizophrenia patients and first-degree unaffected relatives 149
Event-related potentials in schizophrenic patients: clinical and neurophysiological correlates 148
Patterns of structural MRI abnormalities in deficit and nondeficit schizophrenia 148
ABNORMALITIES OF HEMISPHERE ASYMMETRIES AND INTERHEMISPHERIC INTEGRATION IN SCHIZOPHRENIA 148
Evidence-based medicine and electrophysiology in schizophrenia 147
ERP changes induced by antipsychotic drugs 147
Modified nutritional counselling to increase motivation to treatment in anorexia nervosa. 146
Neuropsychological slowness in obsessive-compulsive disorder: Is it limited to tests assessing executive functions? 146
EEG microstate duration and syntax in acute, medication-naïve, first-episode schizophrenia: A multi-center study 145
C-EEG brain mapping in DSM-III schizophrenics after acute and chronic haloperidol treatment 145
An individualized programme of cognitive and psychosocial intervention in psychotic patients 145
External validation of the five domains of negative symptoms: Focus on cognition, functional capacity, and real-world functioning 144
A multivariate approach to investigate the associations of electrophysiological indices with schizophrenia clinical and functional outcome 144
[The importance of recent neuropsychological and neurophysiological studies for social psychiatry] 144
EPA guidance on treatment of negative symptoms in schizophrenia 144
Electrophysiological Correlates of Reward Anticipation in Subjects with Schizophrenia: An ERP Microstate Study 143
Social skills and neurocognitive individualized training in schizophrenia 143
Controllo esecutivo e ritmo alfa nei pazienti con disturbo ossessivo-compulsivo (DOC) 143
Perceived body shape distortions among eating disorders: preliminary evaluation of the behavioral indices of a modified emotional stroop test 143
Body image distortion in eating disorders: a functional magnetic resonance imaging (fMRI) study 142
QEEG indices in the prediction of clinical response to psychotropic drugs 142
Factors influencing the outcome of integrated therapy approach in schizophrenia: A narrative review of the literature 141
Brain regions activated during an auditory discrimination task in bulimic patients: Low-resolution brain electromagnetic tomography applied to event-related potentials 141
Disfunzione dell’emisfero destro nel disturbo da attacchi di panico: uno studio di neuroimmagine ad alta risoluzione temporale 140
Autism Rating Scale: A New Tool for Characterizing the Schizophrenia Phenotype 140
Assessment of Negative Symptoms in Schizophrenia: From the Consensus Conference-Derived Scales to Remote Digital Phenotyping 139
QEEG MAPPING CHANGES AFTER A SINGLE-DOSE AS PREDICTORS OF CLINICAL-RESPONSE TO HALOPERIDOL IN SCHIZOPHRENIA 139
Correlati neurofisiologici della risposta clinica ai neurolettici tipici in pazienti schizofrenici al primo episodio di malattia 138
Auditory P300 topography in deficit and non-deficit schizophrenia 138
ELECTROPHYSIOLOGICAL INDICES OF REWARD ANTICIPATION ABNORMALITIES IN SUBJECTS WITH SCHIZOPHRENIA 138
Characterization of antipsychotic drugs: ERP and LORETA findings 137
EEG-Based Measures in At-Risk Mental State and Early Stages of Schizophrenia: A Systematic Review 137
The Cognitive Assessment Interview (CAI): Association with neuropsychological scores and real-life functioning in a large sample of Italian subjects with schizophrenia 137
Ipercontrollo esecutivo nella sindrome ossessivo-compulsiva: indici neuropsicofisiologici 136
Contributions of psychopatology and cognitive impairment to social functioning in patients with schizophrenia 136
Insight in cognitive impairment assessed with the Cognitive Assessment Interview in a large sample of patients with schizophrenia 135
La Sindrome Ossessivo-Compulsiva in una prospettiva neuropsicologica 135
Stili di attaccamento e funzioni cognitive in un gruppo di pazienti con disturbo del comportamento alimentare 134
Body image distortion in bulimia nervosa: a high temporal resolution brain imaging study. 134
Cognitive functions and psychopathological dimensions in schizophrenia 133
Lateralizzazione emisferica ed eterogeneità legata al sesso nella schizofrenia 133
QEEG alpha 1 changes after a single dose of high-potency neuroleptics as a predictor of short-term response to treatment in schizophrenic patients 133
Totale 17.632
Categoria #
all - tutte 158.720
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 158.720


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.936 0 0 0 79 765 15 39 53 84 95 142 664
2022/20233.893 406 135 42 304 421 289 16 208 1.900 31 63 78
2023/20241.814 152 70 135 157 574 137 49 76 26 35 140 263
2024/20255.977 79 81 100 300 836 834 883 422 786 946 365 345
2025/202621.580 814 1.055 969 973 1.714 11.616 1.273 933 814 658 487 274
2026/20274.093 205 857 1.660 1.371 0 0 0 0 0 0 0 0
Totale 47.178